Gland Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has informed the stock exchanges that the trading window for its securities will be closed from Saturday, March 28, 2026, until 48 hours after the declaration of its audited financial results for the quarter and financial year ending March 31, 2026. This is a standard compliance measure under SEBI's insider trading regulations to prevent insiders from trading while in possession of unpublished financial information. The date of the board meeting to approve these annual results has not yet been announced and will be communicated later. No new financial details, dividends, or business updates are provided in this filing.
This is a routine regulatory disclosure and has no direct impact on the stock price. It signals that Gland Pharma's Q4 and FY26 audited earnings are due soon, which investors should watch for as the next potential catalyst.